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OBJECTIVE: To describe the temporal trends in female breast cancer mortality rates in Brazil in its macro-regions and
states between 1980 and 2009.
METHODS: This was an ecological time-series study using data on breast cancer deaths registered in the Mortality
Data System (SIM/WHO) and census data on the resident population collected by the Brazilian Institute of
Geography and Statistics (IBGE/WHO). Joinpoint regression analyses were used to identify the significant changes in
trends and to estimate the annual percentage change (APC) in mortality rates.
RESULTS: Female breast cancer mortality rates in Brazil tended to stabilize from 1994 onward (APC=0.4%).
Considering the Brazilian macro-regions, the annual mortality rates decreased in the Southeast, stabilized in the
South and increased in the Northeast, North, and Midwest. Only the states of Sao Paulo (APC= -1.9%), Rio Grande
do Sul (APC= -0.8%) and Rio de Janeiro (APC= -0.6%) presented a significant decline in mortality rates. The greatest
increases were found in Maranhao (APC=12%), Paraiba (APC=11.9%), and Piaui (APC=10.9%).
CONCLUSION: Although there has been a trend toward stabilization in female breast cancer mortality rates in
Brazil, when the mortality rate of each macro-region and state is analyzed individually, considerable inequalities are
found, with rate decline or stabilization in states with higher socioeconomic levels and a substantial increase in
those with lower socioeconomic levels.
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INTRODUCTION
Breast cancer is the principal cause of cancer deaths in
women worldwide (1-2). The patterns of mortality rates
generally follow the incidence patterns of the disease (3).
The trend in breast cancer incidence and mortality rates has
remained stable or declined in some developed countries
(1,4,5), largely as a result of a reduction in the use of
menopausal hormone therapy (6), early detection through
mammography screening, and advances in the treatment of
the disease (1,2). However, breast cancer incidence and
mortality have been increasing rapidly among women in
many of the countries of Eastern Europe, Asia, and Latin
America and some African countries (1,2).
The incidence of breast cancer is directly associated with
older age groups (7,8). The Brazilian population is currently
undergoing an accelerated aging process, with changes in
the epidemiological profile of the population reflecting the
slower growth rate in the number of children and
adolescents together with an increase in the economically
active population and the elderly (9).
As a developing country with an emerging economy, the
pattern of breast cancer in Brazil has been changing, and an
increase in incidence has been reported (10). The estimated
number of new cases for 2012 is 52,680, with a risk of
52 cases for every 100,000 women (10). This transition,
however, is occurring in an extremely unbalanced manner,
which is, to a large extent, associated with the different
social conditions present within the country (11). In the
Southeast region, breast cancer is the most common type of
malignancy in women, with an estimated risk of 69 new
cases per 100,000 women, followed by the South (65/
100,000), the Midwest (47/100,000), and the Northeast (32/
100,000). In the North region, it is the second most common
form of cancer in women, with an incidence of 19/100,000
(10).
In the last decade, opportunistic breast cancer screening
in some areas of Brazil and the use of mammography (12,13)
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have allowed the reduction of local advanced diseased and
an increase in early breast cancer detection (14). However,
as of 2004, this modification in the pattern of diagnosis had
not affected breast cancer mortality (15,16), morbidity, or
quality of life, considering different types of surgical
treatment (17).
The continental dimensions of this vast country (9) and
large social and economic disparities might play a role in
breast cancer mortality. However, to date, this question has
not been addressed, limiting the understanding of the
impact of the disease and not allowing for a better use and
allocation of resources according to the needs of each
individual state. Therefore, the objectives of the present
study were to analyze female breast cancer mortality trends
in Brazil considering individual macro-regions and states
for the 1980-2009 period.
METHODS
Study design
This is an ecological time-series study conducted by
collecting data on the number of deaths due to female breast
cancer in Brazil between 1980 and 2009. Because this study
was carried out using secondary open data, there was no
need for Ethics Committee approval.
Brazilian macro-regions and states
Brazil encompasses a total area of 8,514,876 km2 in South
America and consists of 27 states in five geographical
macro-regions: the South, Southeast, Midwest, North, and
Northeast (9). The total population in 2009 was approxi-
mately 191 million inhabitants, and the population density
was 22.5 people/km2.
The South region, consisting of the states of Parana, Santa
Catarina and Rio Grande do Sul, comprises 15% of the
country’s population and has the highest human develop-
ment index (HDI). The Southeast region is composed of the
states of Sao Paulo, Minas Gerais, Rio de Janeiro, and
Espirito Santo and is the most populous (42%) and most
affluent region of Brazil. The states of Mato Grosso, Mato
Grosso do Sul, and Goias and the Federal District, where
Brasilia, the capital of the country, is situated, constitute the
Midwest. This is the least populated region (7%), with the
second lowest population density in the country. The North
region, which is the least densely populated, consists of the
states of Acre, Amapa, Amazonas, Para, Rondonia,
Roraima, and Tocantins. This region includes 45% of the
total area of Brazil and 8% of its total population. The
Northeast region is made up of the states of Bahia, Alagoas,
Ceara, Maranhao, Paraiba, Pernambuco, Piaui, Rio Grande
do Norte, and Sergipe. The population of this region
represents 29% of the total population of the country, and
it is the region with the lowest HDI in Brazil (9).
Data sources
The number of deaths from female breast cancer in the
different Brazilian states and macro-regions and for the
country as a whole was obtained from the reports of deaths
registered in the Mortality Data System (SIM/WHO) and
made available by the DATASUS database (18). The states
of Acre, Roraima, and Amapa were excluded from the
study because data for the period to be analyzed were
missing, while Tocantins was excluded because it only
became an independent state in 1989 (9). During this study,
the International Classification of Diseases (ICD) under-
went two revisions; therefore, data up to 1996 were based
on the ICD-9, and data from 1996 onward were based on
the ICD-10. The consolidated mortality data from 1980 to
2008 and preliminary data for 2009 were included in this
study.
Data on the resident population, which were obtained
from the national censuses conducted in 1980, 1991, and
2000, were extracted from DATASUS. For the intermediate
years, population estimates were derived from the National
Household Sample Surveys (PNAD), which are conducted
annually by the Brazilian Institute of Geography and
Statistics IBGE/WHO (18).
Statistical analysis
Once the data on deaths and the resident population were
obtained, age-specific mortality rates, which were classified
into seven different age groups (20-29, 30-39, 40-49, 50-59,
60-69, 70-79 and $80 years of age), were calculated, and the
age-standardized mortality rates were estimated using an
indirect method with the hypothetical world population
proposed by Segi (1960) and modified by Doll et al. (1966) as
a reference (19).
To identify significant changes in trends, we performed a
joinpoint regression analysis with the software provided by
the Surveillance Research Program of the US National
Cancer Institute (20). With this analysis, it is possible to
identify the years in which a significant change in the linear
slope of the trend (on a log scale) was detected during the
study period (21). The best-fitting points, called ‘‘join-
points’’, are chosen when the rate changes significantly. The
analysis starts with the minimum number of joinpoints
(e.g., 0 joinpoints, which is a straight line) and tests whether
one joinpoint is significant and must be added to the model.
To describe linear trends by period, the estimated annual
percentage change (APC) is then computed for each of
those trends by fitting a regression line to the natural
logarithm of the rates using calendar year as a regressor
variable [i.e., given y = a+bx, where y = ln(rate) and
x = calendar year, the APC is estimated as 100 6 (eb – 1)]
(20,21).
An increase in mortality rates was considered to have
occurred when the trend was toward growth and the
minimum value of the confidence interval was .0.
Conversely, a reduction was considered to have occurred
when there was a decline in the trend and the maximum
value of the confidence interval was ,0. Stability was
defined when, regardless of the trend, the confidence
interval included zero.
RESULTS
Between 1980 and 2009, 213,486 cases of death from female
breast cancer were registered in Brazil. The standardized
mortality rate increased from 9.2 per 100,000 women in 1980
to 11.3 per 100,000 in 2009. A change occurred in the mortality
trend in Brazil. Initially, between 1980 and 1994, an annual
increase of 1.6% was registered; however, from 1994 onward,
the rates tended to stabilize, with an annual increase of 0.4%,
as shown in Table 1. The highest mortality rates were found
in the South and Southeast regions of the country, with
maximum values of 14.6/100,000 women in 1997 and 14.4/
100,000 in 1994, respectively. Nevertheless, these were the
regions in which the female breast cancer mortality rates
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tended to decline or stabilize (Table 1). In the South,
stabilization occurred from 1994 onwards. In the Southeast,
a significant change occurred in the mortality rates in 1997,
from an increase of 1.2% between 1980 and 1997 to a decrease
of -0.9% between 1997 and 2009.
In the Midwest and North regions, increases in the breast
cancer mortality rates in women of 1.9% and 2.4%,
respectively, were found during the period analyzed. An
increase in mortality was also registered in the Northeast
region of the country, with an increase of 2.1% between 1980
and 2000 and 5.3% from 2000 onward.
When female breast cancer mortality trends were ana-
lyzed in the different states in Brazil (Table 2), a significant
decrease was found in three states: Sao Paulo (-1.9% from
1999 onward), Rio Grande do Sul (-0.8% from 1993 onward),
and Rio de Janeiro (-0.6% from 1994 onward). In all of these
states and in the Federal District, the capital of the country,
the breast cancer mortality rates for women were higher.
The maximum value for Rio de Janeiro was 18.8/100,000
women in 1994, followed by the Federal District (18.4/
100,000 in 2006), Rio Grande do Sul (17.1/100,000 in 1993),
and Sa˜o Paulo (16.7/100,000 in 1999) (Figure 1).
In the states of Parana and Santa Catarina and the Federal
District, the breast cancer mortality rates stabilized, as
shown in Table 2. An increase occurred in the breast cancer
mortality rates in women in 17 states, primarily those
situated in the Northeast region of the country, particularly
the states of Maranhao (APC of 12% from 2002 onward),
Paraiba (APC of 11.9% from 2000 onward), and Piaui (APC
of 10.9% from 1997 onward).
Table 1 - Female breast cancer mortality trends between 1980 and 2009 in Brazil and the macro-regions of the country.
Brazil and its Trend 1 Trend 2
macro-regions Period Mortality Rate Period Mortality Rate
Initial Final Initial Final APC (95% CI; p-value) Initial Final Initial Final APC (95% CI; p-value)
Brazil 1980 1994 9.2 11.7 1.6* (1.1–2.1; p,0.01) 1994 2009 11.7 11.3 0.4 (-0.1–0.8; p= 0.08)
South 1980 1994 10.9 14.4 2.2* (1.5–3.0; p,0.01) 1994 2009 14.4 12.7 -0.3 (-1.0–0.3; p= 0.31)
Southeast 1980 1997 12.3 14.6 1.2* (0.8–1.6; p,0.01) 1997 2009 14.6 12.6 -0.9* (-1.6–-0.2; p,0.01)
Midwest 1980 2009 5.3 10.4 1.9* (1.5–2.4; p,0.01)
North 1980 2009 4.1 6.6 2.4* (1.9–3.0; p,0.01)
Northeast 1980 2000 4.2 6.1 2.1* (1.7–2.5; p,0.01) 2000 2009 6.1 9.0 5.3* (3.9–6.7; p,0.01)
Standardized mortality rate per 100,000 women.
*Statistically significant; p,0.05.
Table 2 - Trends in female breast cancer mortality rates between 1980 and 2009 in the states of Brazil.
States Trend 1 Trend 2
Period Mortality Rate Period Mortality Rate
Initial Final Initial Final APC (95% CI; p-value) Initial Final Initial Final APC (95% CI; p-value)
Parana 1980 2002 8.3 13.1 2.2* (1.7–2.8; p,0.01) 2002 2009 13.1 11.8 -1.3 (-4.0–1.6; p= 0.35)
Santa Catarina 1980 1998 8.9 12.5 2.1* (1.4–2.8; p,0.01) 1998 2009 12.5 11.3 -0.6 (-2.0–0.9; p= 0.43)
Rio Grande do
Sul
1980 1993 13.4 17.1 2.1* (1.1–3.1; p,0.01) 1993 2009 17.1 13.9 -0.8* (-1.4– -0.1; p= 0.03)
Espirito Santo 1980 2009 6.5 10.3 2.1* (1.5–2.7; p,0.01)
Rio de Janeiro 1980 1994 17.0 18.8 1.2* (0.6–1.8; p,0.01) 1994 2009 18.8 16.3 -0.6* (-1.1– -0.1; p= 0.03)
Sa˜o Paulo 1980 1999 12.5 16.7 1.2* (0.9–1.6; p,0.01) 1999 2009 16.7 12.7 -1.9* (-2.9– -0.9; p,0.01)
Minas Gerais 1980 2009 7.7 9.2 0.7* (0.4–1.0; p,0.01)
Goias 1980 2009 4.1 9.8 2.0* (1.3–2.6; p,0.01)
Mato Grosso
do Sul
1980 2009 6.3 11.8 2.2* (1.4–3.1; p,0.01)
Mato Grosso 1980 2009 2.5 8.9 4.3* (3.4–5.1; p,0.01)
Federal District 1980 2006 11.5 18.4 1.1* (0.4–1.8; p,0.01) 2006 2009 18.4 12.1 -11.0 (-25.9–7.0; p= 0.20)
Amazonas 1980 2009 4.3 6.4 2.1* (1.0–3.2; p,0.01)
Para 1980 2009 4.6 6.4 1.6* (0.9–2.4; p,0.01)
Rondonia 1980 2009 1.3 9.5 4.5* (2.9–6.2; p,0.01)
Bahia 1980 2001 4.7 5.7 1.3* (0.7–1.8; p,0.01) 2001 2009 5.7 7.7 4.4* (2.0–6.1; p,0.01)
Rio Grande do
Norte
1980 1986 3.1 5.4 9.7* (0.9–19.2; p= 0.03) 1986 2009 5.4 9.7 2.3* (1.2–3.4; p,0.01)
Maranhao 1980 2002 1.2 2.5 3.0* (1.4–4.7; p,0.01) 2002 2009 2.5 5.8 12.0* (2.5–22.3; p= 0.01)
Piaui 1980 1997 2.2 2.7 0.3 (-2.2–2.8; p= 0.80) 1997 2009 2.7 8.5 10.9* (6.3–15.7; p,0.01)
Paraiba 1980 2000 3.5 3.3 1.6* (0.4–2.9; p= 0.01) 2000 2009 3.3 9.5 11.9* (7.3–16.7; p,0.01)
Alagoas 1980 1996 5.1 2.6 -1.1 (-2.4–0.2; p= 0.08) 1996 2009 2.6 8.7 6.1* (4.2–8.0; p,0.01)
Sergipe 1980 1983 5.5 2.7 -17.4 (-39.7–12.9; p= 0.21) 1983 2009 2.7 12.5 4.2* (3.0–5.4; p,0.01)
Ceara 1980 2009 3.6 9.9 3.8* (3.2–4.3; p,0.01)
Pernambuco 1980 2009 6.2 11.1 2.7* (2.4–3.1; p,0.01)
Standardized mortality rate per 100,000 women.
*Statistically significant; p,0.05.
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DISCUSSION
This analysis of the trends in female breast cancer
mortality in Brazil reveals a positive pattern in recent
years, reflecting a leveling of the rates. These findings
contradict the expected patterns for developing, low-
income countries (1,2) and differ from some studies that
reported an increase in mortality in other periods (4,22).
However, the present results correlate with other studies
(15,16) in which a general trend toward stabilization was
found in breast cancer rates up to 1994, indicating that
advances were being achieved in the treatment of breast
cancer and the availability of mammography screening
programs, resulting in earlier detection (1,5). Despite this
supposedly favorable scenario and although breast cancer
mortality rates remain constant, considerable increases will
occur in the absolute number of deaths as a result of
population growth and increased life expectancy because
of the strong association between the risk of cancer and age
(23).
The exact number of breast cancer deaths registered in the
country as a whole and the North region in particular is
unknown due to incomplete notification in some states.
Irregularities are known to have occurred in the registration
of deaths in the majority of the states in the North region
and in some states in the Northeast in 1980 (24). However, a
significant improvement was achieved in the quality of
reports in 1990, with the coverage of deaths increasing, thus
enabling reliable mortality indicators to be produced.
Currently, there are 19 hospital population-based cancer
registries in Brazil. Over time, a significant improvement in
the quality of mortality data in the country has been noted,
which is indicated by the reduction in the deaths classified
as ‘‘ill-defined causes’’, mostly from 2005. However, there is
still a certain degree of underreporting (10). The database
quality in a cancer registry depends on the quality of its
Figure 1 - Female breast cancer mortality rates in the states of Brazil from 1980 to 2009 (5-year average annual mortality rates). The
states are grouped in accordance with their macro-regions.
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sources and its registration criteria. These methods should
follow the international standard so that the worldwide
population can be compared consistently (25).
It is crucial that cancer mortality data are standardized,
updated, properly recorded, representative of the popula-
tion, and disseminated in a timely manner as a tool for the
epidemiologic surveillance of cancer in the country. In this
way, careful interpretation and usage of the estimates are
necessary when analyzing time trends. Such an approach is
important due to changes in the methodology and the best
quality of data over time (10).
As shown, significant regional differences exist in Brazil
with respect to female breast cancer mortality rates,
reproducing a similar pattern to those observed around the
world (1-6). Although the Southeast (the most developed
region) generally has the highest mortality rates, when
temporal trends are analyzed, a pattern of decline is found,
which is in line with trends identified in a large proportion of
developed countries over the past 25 years (1,2,5). In the
United States, an annual decrease of 2.5% has been observed,
with similar findings in various European countries, such as
France (-1.4%), Italy (-1.6%), and Germany (21.5%) (1,2,5).
However, the greatest increase (5.3%) was found in the
Northeast, a region of medium and low development, in
agreement with trends observed in some African and Asian
countries, including South Korea and India (2).
Breast cancer is associated with industrialization, and the
risk of the disease is related to higher socioeconomic levels,
older age groups, low parity, early menarche and late
menopause, obesity and alcohol consumption (10,26).
Accordingly, the results of the present study show that the
risk of dying from female breast cancer in Brazil is at least
twofold higher in states such as Sao Paulo, Rio de Janeiro,
Rio Grande do Sul and the Federal District, where HDIs are
higher, compared with the states of Alagoas, Maranhao and
Piaui. Social inequalities regarding the access to and use of
healthcare services are also present in this country, as
reflected in the different breast cancer mortality trends
found within Brazil.
Mammography screening is known to reduce breast
cancer mortality rates through early diagnosis (27). In
Brazil, mammography coverage is lower in the North and
in some states of the Northeast, with coverage levels that
range from 64% to 84% (28). According to the National
Cancer Institute (INCA), mammography coverage ranges
from 37% to 67% (29) in 15 state capital cities and the
Federal District, which partially explains the different
trends in breast cancer mortality shown in this paper,
ranging from a decrease of 0.9% in the Southeast to an
increase of 5.3% in the Northeast. These inequalities are
even greater when the different states of Brazil are analyzed
separately, with values ranging from a decline of 1.9% in
Sao Paulo to a substantial increase of 12% in Maranhao.
Due to the immense inequalities between regions in
Brazil, the specifications of each individual region need to
be considered because they indicate different patterns
within the demographic transition. In the South, mortality
from breast cancer is higher in Rio Grande do Sul compared
with the states of Santa Catarina and Parana, as has also
been shown in other studies (10,30), suggesting hetero-
geneity in the profiles of exposure to risk factors and in
lifestyle and genetic factors (30). However, contrary to the
results of these previous studies, the present findings
suggest stabilization and a decline in breast cancer mortality
in women in the South, principally in Rio Grande do Sul,
where a decline of 0.8% has occurred since 1993.
In the Southeast, the mortality rates are higher in Rio de
Janeiro and Sao Paulo, confirming data published by INCA
(10). However, there was a significant decline in breast cancer
mortality in women in the states of Rio de Janeiro and Sao
Paulo. The 1.9% decline found in Sao Paulo from 1999
onward is particularly noteworthy and suggests advances in
treatment. The Sao Paulo State Health Department, in
collaboration with the Women’s Health Referral Center, the
Department of Breast Diseases of the Federal University of
Sao Paulo (UNIFESP) and the Oncocenter Foundation, is
developing a strategic plan to reduce breast cancer mortality.
This type of action in association with a center for efficient
case resolution (CARE) may help provide immediate and
individualized treatment (29).
In the Midwest region, the Federal District, the capital of
the country, has the highest mortality rates from breast cancer
in women compared with Mato Grosso do Sul, Goias, and
Mato Grosso, following patterns similar to those found in Sao
Paulo, Rio de Janeiro, and Rio Grande do Sul. Nevertheless,
the 11% decline in mortality registered over the past four
years in the Federal District may be due to advances in the
Brazilian National Health System (SUS) (30,31) in addition to
regulations and guidelines within the SUS network that
prevent the migration of residents from other states. This
would explain the steep decline in mortality in the Federal
District and justify the increase in mortality rates in recent
years in the northeastern states because patients with breast
cancer would migrate from the states with poorer healthcare
conditions to the Federal District, where the public healthcare
network is well established and well developed.
In the North, breast cancer is the second cause of
mortality from cancer in women, preceded only by cervical
cancer (10). These data show an annual increase of 2.4% in
the mortality rate. The profile of the individual states is
similar, with increases that range from 4.5% in Rondonia to
1.6% in Para. This vast region is composed of extensive
areas of unpopulated territory such as that occupied by the
Amazon forest (11); however, it is a region in which the
population is increasing rapidly (11). Considering these
facts and the unfavorable trend in mortality, breast cancer
continues to be of fundamental importance to public health
in this region.
Socioeconomic indicators in the Northeast region are
precarious (9). In parallel, the greatest increase in female
breast cancer mortality was found in this region. An increase
of 5.3% occurred between 2000 and 2009, with variation
between the states that ranged from a 1.1% decline in Alagoas
between 1980 and 1996 (thereafter increasing by 6.1%) to a
12% increase in Maranhao between 2002 and 2009. It is
possible that some of these fluctuations may be the result of
changes in the practices of codification and registration and
modifications to regulations concerning migration within the
SUS network because the inverse occurred in the Federal
District (30). Nevertheless, in these states, breast cancer
mortality was found to follow the patterns expected for
developing and less developed regions (1,2). The maximum
mortality rates ranged from 5.8 per 100,000 women in
Maranhao to 12.5/100,000 in Sergipe.
In 2004, a consensus document was drawn up to promote
the early detection of breast cancer in Brazil, with the
development of public policies adapted to the reality of the
infrastructure in the country (32). The current major
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challenge facing Brazil is related to the difficulty encoun-
tered by patients in accessing the few centers in the country
that specialize in breast cancer treatment. Furthermore, even
these centers are often inadequately equipped to provide
speedy diagnosis and treatment, resulting in patients
migrating from areas in which healthcare is deficient to
areas where access is easier, consequently overloading and
burdening existing centers (29). In many regions of the
country, the distribution of consultations was found to be
poor, and access to treatment was difficult for women of
lower socioeconomic levels (28,33,34).
The socioeconomic inequalities present in this country are
most likely affecting mortality patterns despite the increased
knowledge of risk factors for breast cancer, the improvement
in mammography screening programs, resulting in the
early detection of cases, and the advances achieved in the
treatment of the disease (26,35,36). Therefore, although the
risk of breast cancer is higher among women living in areas in
which socioeconomic conditions are better (35,36), economic-
ally deprived women are at an increased risk of dying from
breast cancer (36).
Conclusions and policy implications
Although there has been a trend toward stabilization in the
female breast cancer mortality rates in Brazil, when the
mortality rate of each state is analyzed individually,
considerable inequalities are found, with rate decline or
stabilization in states with higher socioeconomic levels and a
substantial rate increase in those with lower socioeconomic
levels. In the majority of developing states, the mortality rates
are increasing. Therefore, female breast cancer mortality
should be studied in greater detail in view of the significant
changes in the annual percentages, particularly in regions
where the level of development is low.
The epidemiological data presented in this study provide
further scientific knowledge on the temporal trends of
female breast cancer in Brazil in each macro-region of the
country and in each state. These data highlight important
differences in the pattern of breast cancer mortality in
Brazil and, for the first time, show a decline in female
breast cancer mortality in some states and macro-regions of
the country.
The relevance of these findings lies in the fact that they
provide scientific data on which to base future decision
making, primarily with respect to the northeast of the
country, where the greatest increases in mortality were
found. Therefore, although Brazil must be considered as a
whole, the priority in terms of primary and secondary
preventive actions should be established for the less
developed regions of the country.
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